Sort
15,273 grants matching “antimicrobial resistance”
Investigating Neisseria gonorrhoeae chromosomal replication dynamics
$80,224Iryna Boiko · Northwestern University At Chicago · F32 · FY2025 · AI
Viruses Hijack Innate Immune Peptides to Enhance Infection
$80,224Kaitlin Rose Hulce · University Of Washington · F32 · FY2025 · AI
Synthesis of Natural and Unnatural Inhibitors of ftsZ
$80,073Jared Thomas Shaw · Harvard University · R03 · FY2006 · AI
Molecular mechanisms of gasdermins and pyroptosis
$80,062Tsan Sam Xiao · Case Western Reserve University · R01 · FY2019 · GM
Mechanical deformation of the cell envelope as a form of surface-sensing in Pseudomonas aeruginosa
$80,020Kelsey Gray Defrates · University Of California, San Francisco · F32 · FY2025 · AI
Anti-biofilm laser-mediated photothermal ablation via complex noble metal nanostructures
$80,017Maryam Hajfathalian · University Of Pennsylvania · K99 · FY2020 · EB
Collaborative Research: Impacts of biocides associated with hydraulic fracturing on aquatic microbial communities.
$80,000Terry C Hazen · University Of Tennessee Knoxville · · FY2018 · ENG
Phase IV Trial to Evaluate Antimicrobial Therapy of Community Acquired Pneumonia in Children - VTEU
$79,911David Bernstein · Cincinnati Childrens Hosp Med Ctr · N01 · FY2015 · AI
Urothelial IL-6 Signaling in the Host Defense Against Urinary Tract Infections
$79,909Christina B Ching · Research Inst Nationwide Children'S Hosp · K08 · FY2023 · DK
Novel Mouse Models to Assess the in vivo Significance of Ribonuclease 7 in Urinary Tract Defense
$79,850John David Spencer · Research Inst Nationwide Children'S Hosp · R03 · FY2016 · DK
Development of Neutrophil-Avid Nanocarriers as an Antibiotic Delivery System
$79,386Kathryn Rubey · Children'S Hosp Of Philadelphia · F32 · FY2021 · HL
The role of enteric pathogens and antimicrobial resistance in driving clinical and nutritional deterioration, and azithromycin's potential effect, among children discharged from hospital in Kenya
$79,253Patricia Pavlinac · University Of Washington · R01 · FY2023 · AI
Salivary MUC7 Antimicrobial Peptide:RIM101 Response and Mechanism of Action.
$79,250Maciej Miroslaw Lis · State University Of New York At Buffalo · R03 · FY2010 · DE
Salivary MUC7 Antimicrobial Peptide:RIM101 Response and Mechanism of Action.
$79,250Maciej Miroslaw Lis · State University Of New York At Buffalo · R03 · FY2011 · DE
Phagosomal Ion Channels as Therapeutic Targets
$79,179Deborah J. Nelson · University Of Chicago · R01 · FY2017 · HL
Social and biomedical risk factors for multi-drug resistant TB in rural China
$79,118Biao Xu · Fudan University · R01 · FY2008 · AI
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
$79,028Alice S Prince · Columbia University Health Sciences · R35 · FY2019 · HL
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
$79,028Alice S Prince · Columbia University Health Sciences · R35 · FY2022 · HL
Administrative Core
$78,908Tim Van Opijnen · Boston Children'S Hospital · U19 · FY2025 · AI
In vitro Pharmacokinetic/pharmacodynamic models for dose de-escalation of antibiotics
$78,750Razi Kebriaei · Ohio State University · R03 · FY2025 · AI
In vitro Pharmacokinetic/pharmacodynamic models for dose de-escalation of antibiotics
$78,750Razi Kebriaei · Ohio State University · R03 · FY2024 · AI
PHFE/CEIP NARMS Retail Food Surveillance Program
$78,643Duc J Vugia · Public Health Foundation Enterprises · U01 · FY2019 · FD
High Throughput Screening: Bacterial Mechanosensitive Channels as Drug Targets
$78,500Paul L Blount · Ut Southwestern Medical Center · R03 · FY2009 · AI
Gene Essentiality in Mycobacterium kansasii
$78,500Luis E Quadri · Brooklyn College · R03 · FY2018 · AI
Gene Essentiality in Mycobacterium kansasii
$78,500Luis E Quadri · Brooklyn College · R03 · FY2019 · AI